A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer

CONCLUSION: Neoadjuvant chemoradiotherapy combined with ICIs demonstrated favorable efficacy and safety in treating LARC patients.PMID:38583351 | DOI:10.1016/j.tranon.2024.101955
Source: Translational Oncology - Category: Cancer & Oncology Authors: Source Type: research